Dr. Bruce Friedman, M.D

NPI: 1417939315
Total Payments
$1.0M
2024 Payments
$20,706
Companies
41
Transactions
1,242
Medicare Patients
536
Medicare Billing
$225,380

Payment Breakdown by Category

Other$777,069 (74.4%)
Travel$171,902 (16.5%)
Consulting$65,444 (6.3%)
Food & Beverage$26,345 (2.5%)
Education$3,404 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $422,294 166 40.4%
Honoraria $184,708 67 17.7%
Travel and Lodging $171,902 530 16.5%
Compensation for serving as faculty or as a speaker for a medical education program $134,418 33 12.9%
Consulting Fee $65,444 32 6.3%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $35,650 14 3.4%
Food and Beverage $26,345 393 2.5%
Education $3,404 7 0.3%

Top Paying Companies

Company Total Records Latest Year
Shionogi Inc $157,577 133 $0 (2024)
La Jolla Pharmaceutical Company $122,910 85 $0 (2023)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $115,095 103 $0 (2023)
PORTOLA PHARMACEUTICALS, LLC $113,854 133 $0 (2020)
Melinta Therapeutics, LLC $72,577 110 $0 (2023)
Mallinckrodt LLC $61,014 84 $0 (2018)
AcelRx Pharmaceuticals, Inc. $60,476 80 $0 (2020)
Merck Sharp & Dohme LLC $54,106 88 $0 (2023)
Collegium Pharmaceutical, Inc. $52,609 83 $0 (2018)
The Medicines Company $52,434 92 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $20,706 12 Shionogi Inc ($20,706)
2023 $95,104 76 Shionogi Inc ($53,124)
2022 $126,179 112 Shionogi Inc ($50,562)
2021 $88,201 74 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($30,031)
2020 $45,895 76 AcelRx Pharmaceuticals, Inc. ($11,134)
2019 $221,239 264 AcelRx Pharmaceuticals, Inc. ($49,341)
2018 $200,618 243 La Jolla Pharmaceutical Company ($64,657)
2017 $246,221 385 Mallinckrodt LLC ($58,410)

All Payment Transactions

1,242 individual payment records from CMS Open Payments — Page 1 of 50

Date Company Product Nature Form Amount Type
10/02/2024 Shionogi Inc Fetroja (Drug) Travel and Lodging Cash or cash equivalent $100.50 General
Category: Infections and Infectious Diseases
10/02/2024 Shionogi Inc Fetroja (Drug) Food and Beverage Cash or cash equivalent $6.90 General
Category: Infections and Infectious Diseases
08/28/2024 Shionogi Inc Fetroja (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $6,075.00 General
Category: Infections and Infectious Diseases
08/06/2024 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $123.98 General
Category: Infections and Infectious Diseases
07/23/2024 Shionogi Inc Fetroja (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $6,075.00 General
Category: Infections and Infectious Diseases
07/23/2024 Shionogi Inc Fetroja (Drug) Travel and Lodging Cash or cash equivalent $219.76 General
Category: Infections and Infectious Diseases
07/16/2024 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $53.04 General
Category: Infections and Infectious Diseases
04/26/2024 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $14.91 General
Category: Infections and Infectious Diseases
03/13/2024 Shionogi Inc Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $675.00 General
01/21/2024 Shionogi Inc Fetroja (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $6,075.00 General
Category: Infections and Infectious Diseases
01/21/2024 Shionogi Inc Fetroja (Drug) Travel and Lodging Cash or cash equivalent $731.00 General
Category: Infections and Infectious Diseases
01/21/2024 Shionogi Inc Fetroja (Drug) Travel and Lodging Cash or cash equivalent $555.97 General
Category: Infections and Infectious Diseases
12/20/2023 Shionogi Inc Travel and Lodging Cash or cash equivalent $172.91 General
11/30/2023 Shionogi Inc Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $2,500.00 General
11/30/2023 Shionogi Inc Food and Beverage In-kind items and services $63.24 General
11/30/2023 Shionogi Inc Food and Beverage In-kind items and services $47.37 General
11/30/2023 Shionogi Inc Food and Beverage In-kind items and services $35.72 General
11/29/2023 Shionogi Inc Fetroja (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $4,050.00 General
Category: Infections and Infectious Diseases
11/29/2023 Shionogi Inc Travel and Lodging Cash or cash equivalent $551.40 General
11/29/2023 Shionogi Inc Travel and Lodging Cash or cash equivalent $305.56 General
11/29/2023 Shionogi Inc Food and Beverage In-kind items and services $140.28 General
11/29/2023 Shionogi Inc Food and Beverage In-kind items and services $70.30 General
11/29/2023 Shionogi Inc Travel and Lodging Cash or cash equivalent $30.56 General
11/29/2023 Shionogi Inc Fetroja (Drug) Food and Beverage Cash or cash equivalent $17.91 General
Category: Infections and Infectious Diseases
11/28/2023 Shionogi Inc Fetroja (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $6,075.00 General
Category: Infections and Infectious Diseases

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 114 383 $207,685 $47,028
2022 6 134 413 $222,705 $49,743
2021 5 133 402 $243,690 $53,539
2020 6 155 580 $327,600 $75,069
Total Patients
536
Total Services
1,778
Medicare Billing
$225,380
Procedure Codes
22

All Medicare Procedures & Services

22 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 41 216 $159,840 $34,970 21.9%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 28 112 $31,360 $9,854 31.4%
36556 Insertion of non-tunneled central venous tube for infusion (5 years or older) Facility 2023 16 20 $12,600 $1,287 10.2%
36620 Insertion of artery tube for blood sampling or infusion through skin Facility 2023 18 23 $3,105 $786.14 25.3%
76937 Ultrasonic guidance for blood vessel access Facility 2023 11 12 $780.00 $131.04 16.8%
99291 Critical care, first 30-74 minutes Facility 2022 40 226 $167,240 $37,831 22.6%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 32 75 $21,000 $5,729 27.3%
99183 Management of oxygen chamber therapy Facility 2022 11 48 $15,840 $3,750 23.7%
36556 Insertion of non-tunneled central venous tube for infusion (5 years or older) Facility 2022 18 23 $14,490 $1,500 10.4%
36620 Insertion of artery tube for blood sampling or infusion through skin Facility 2022 17 21 $2,835 $721.35 25.4%
76937 Ultrasonic guidance for blood vessel access Facility 2022 16 20 $1,300 $211.26 16.3%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 58 278 $205,720 $46,089 22.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 24 61 $17,080 $4,839 28.3%
36556 Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled Facility 2021 19 27 $17,010 $1,717 10.1%
36620 Insertion of arterial catheter for blood sampling or infusion, accessed through the skin Facility 2021 20 22 $2,970 $749.80 25.2%
76937 Ultrasound guidance for accessing into blood vessel Facility 2021 12 14 $910.00 $143.92 15.8%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 50 333 $246,420 $58,240 23.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 26 116 $38,000 $9,465 24.9%
99183 Management and supervision of oxygen chamber therapy per session Facility 2020 14 40 $13,200 $3,370 25.5%
36556 Insertion of central venous catheter for infusion, patient 5 years or older Facility 2020 26 39 $24,570 $2,685 10.9%
36620 Insertion of arterial catheter for blood sampling or infusion, accessed through the skin Facility 2020 20 29 $3,915 $1,047 26.7%
76937 Ultrasound guidance for accessing into blood vessel Facility 2020 19 23 $1,495 $263.12 17.6%

About Dr. Bruce Friedman, M.D

Dr. Bruce Friedman, M.D is a Critical Care Medicine healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417939315.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Friedman, M.D has received a total of $1.0M in payments from pharmaceutical and medical device companies, with $20,706 received in 2024. These payments were reported across 1,242 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($422,294).

As a Medicare-enrolled provider, Friedman has provided services to 536 Medicare beneficiaries, totaling 1,778 services with total Medicare billing of $225,380. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.

Practice Information

  • Specialty Critical Care Medicine
  • Other Specialties Internal Medicine
  • Location Augusta, GA
  • Active Since 11/16/2005
  • Last Updated 10/03/2011
  • Taxonomy Code 207RC0200X
  • Entity Type Individual
  • NPI Number 1417939315

Products in Payments

  • Fetroja (Drug) $143,476
  • RELISTOR (Drug) $108,542
  • GIAPREZA (Drug) $107,098
  • OFIRMEV (Drug) $61,014
  • DSUVIA (Drug) $60,476
  • ANDEXXA (Biological) $59,343
  • BEVYXXA (Drug) $55,028
  • Xtampza ER (Drug) $52,609
  • NUZYRA (Drug) $46,678
  • ZERBAXA (Drug) $45,070
  • VIBATIV (Drug) $36,801
  • Baxdela (Drug) $34,026
  • Vabomere (Drug) $30,920
  • MINOCIN IV (Drug) $30,273
  • XERAVA (Drug) $15,621
  • CRESEMBA (Drug) $15,581
  • VABOMERE (Drug) $14,216
  • Dermatology and Wound Care (Medical Supply) $13,671
  • Xerava (Drug) $11,215
  • AVYCAZ (Drug) $9,350

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Critical Care Medicine Doctors in Augusta